When platelets are activated, arachidonate is enzymatically released from platelet membrane phospholipids and subsequently converted via cyclo-oxygenase and thromboxane synthetase into the cylic endoperoxides, PGG2 and PGH2 and to thromboxane A2 (TXA2).'IThese compounds and especially TXA2 are potent inducers of platelet aggregationf and granule secretion. It has been suggested that TXA2 may act as a calcium ionophore, releasing stored calcium from the dense tubular system and thus raising the level of free cytoplasmic calcium.2
When platelets are activated, arachidonate is enzymatically released from platelet membrane phospholipids and subsequently converted via cyclo-oxygenase and thromboxane synthetase into the cylic endoperoxides, PGG2 and PGH2 and to thromboxane A2 (TXA2).'IThese compounds and especially TXA2 are potent inducers of platelet aggregationf and granule secretion. It has been suggested that TXA2 may act as a calcium ionophore, releasing stored calcium from the dense tubular system and thus raising the level of free cytoplasmic calcium. 2 Mobilisation of intracellular calcium is involved in the regulation of several platelet functions and secretory processes, suggesting a controlling trigger role for intracellular calcium flux and free cytoplasmic calcium in the platelet activation process. 3 Recently, a few patients have been described with a lifelong bleeding tendency in whom arachidonate metabolism including TXA2 formation was normal but whose platelets were unresponsive to TXA2 showing defective aggregation and granule release.4-8 Also a similar acquired defect has been reported in one patient with chronic myeloid leukaemia.9
We present here a patient with a lifelong bleeding tendency who has abnormal aggregation and secretion responses suggestng a defect in either the mobilisation of intracellular calcium, or a response to free cytoplasmic calcium.
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CASE REPORT
A 57-year-old Caucasian housewife presented with a lifelong bleeding disorder. As a child, she had frequent epistaxis lasting up to 24 h at a time until 16 years old. Since then, she has had widespread spontaneous non-traumatic purpura but not excesgive menstrual loss or serious bleeding episodes. She had no operations in the past and had previously been told to avoid all drugs. She did not imbibe alcohol. A family history was relevant in that two brothers died in childhood from uncontrollable haemorrhage after minor trauma in one case and abdominal surgery in the other. Two other sisters and a brother were untroubled by bleeding, one sister having had an uncomplicated appendicectomy. Her parents had lived into old age without any bleeding problems. Physical examination was normal apart from some purpuric lesions on the lower limbs. Initial studies showed a normal blood and platelet count, normal renal and liver biochemical profiles and normal concentrations of immunoglobulin.
Methods
As anticoagulant, one volume of 3 13 % sodium citrate was used for nine volumes of blood. Platelet-rich plasma (PRP) and platelet-poor plasma (PPP) were prepared by centrifugation at 164 g for 10 min and 1465 g for 15 min respectively at 22°C. Bleeding times were performed by the template method using a Simplate-II from General 1140
Defective platelet aggregation to the calcium ionophore A23187 Diagnostics. Platelet counts were performed using a Technicon Autocounter (Technicon Instruments). Coagulation parameters were performed by standard techniques.'0
The patient had been examined on four occasions. On each occasion a healthy control subject, who had ingested no drugs for the previous 14 days, and a control subject who had ingested 900 mg of acetylsalicylic acid 12 h previously, were studied simultaneously.
Platelet-aggregation studies were performed with an Aggregraph dual-channel aggregometer at 37°C. Aliquots of PRP (500 ul) or washed platelet suspensions, with a final platelet count of 200-300 x 109/1 were placed in a cuvette in the aggregometer and aggregation induced with a final concentration of 2-16 ,umolI adenosine-5'-diphosphate (ADP Sigma), 1-2 /umoUl arachidonic acid, sodium salt (Sigma), 1.0-1'5 mg/ml ristocetin (H Lundbeck, Copenhagen), 1-6 ,ug/ml collagen (Hormon Chemie, Munchen), 0-5-2-5 mg/ml endoperoxide analogue U-44069 (kindly supplied by Dr GL Bundy, Upjohn, Kalamazoo, Michigan), 1-12*5 ,4moHl ionophore A23187 (Calbiochem, La Jolla, California), 0*5-2-5 mg/ml. PAF-acether
( 1-0-alkyl -2-acetyl-glyceryl-3-phosphorylcholine; Calbiochem, La Jolla, California) and 0.2-1-0 U/ml human thrombin (Blood Products Laboratory, Elstree, UK). Platelets were washed by an albumin gradient separation technique" and resuspended in a calcium-free TRIS HCl buffered saline, pH 7.4.
Platelet electron microscopy, thromboxane B2 (TXB2) in serum and after release from platelets in response to various stimuli, malondialdehyde (MDA) formation after stimulation with 1 mmoIIl N-ethylmaleimide (NEM), plasma 6-keto prostaglandin Fla and cyclic AMP levels in unstimulated PRP were assayed as previously described.'2 Platelet lysate was examined for antigenic material related to platelet PF4 and factor VIII:Rag.'3
The concentrations of the platelet nucleotides ATP and ADP and their release after platelet stimulation by various agonists were determined by the firefly-luminescence method as described previously.'4 The PRP was corrected to a final platelet count of 300 x 109/l in all experiments involving platelet nucleotide determinations.
Results
The patient consistently had a prolonged bleeding time of >30 minutes with a platelet count ranging between 223-357 x 109/l. All the coagulation parameters including the thrombin time, prothrombin time, activated partial thromboplastin time, factor VIII:C, factor VIII:Rag and factor VIII:RiCoF gave normal results.
Aggregation tracings of the patients and normal control PRP in response to ADP, collagen, arachidonic acid, U44069, A23187 and PAFacether are shown in Fig. 1 . Aggregation was reversible with ADP (2-16 umoHl), with the endoperoxide analogue U44069 (0.5-2.5 ug/ml) and with PAF-acether (0-05-0.5 ug/ml). Aggregation was delayed and reduced in response to arachidonic acid (0.5-2 mmol/l) collagen (1-6 ,ugml) and the calcium ionophore A23187 (1-12.5 umol/l). Ristocetin (1.0-1.5 mg/ml) gave normal aggregation. Upon stimulation the patient's platelets underwent a normal shape change to all the above agonists. Aggregation of washed platelets with thrombin (0*2-1X0 U/mI) was normal. Normal washed platelets do not form platelet aggregates in response to A23187
(1-2 ,tmol/1),'5 but on the addition of 0-5 mmol/I exogenous calcium both control and the patient's washed platelets produced similar aggregation responses.
In a transfer experiment, PRP from the patient and control were stirred in the aggregometer for 30 s after the addition of 1 mmol/I arachidonic acid. After rapid centrifugation for 30 s, 100 ,ul of each platelet poor supernatant was added to 400 Iul of PRP from the patient or from a normal subject who had ingested 900 mg of aspirin 12 hours previously. These mixtures were stirred in the aggregometer and aggregation recorded (Fig. 2) . Supernatant from the control induced full aggregation of the aspirintreated PRP but none with the patient's PRP. Similarly supernatant from the patient induced full aggregation of the aspirin-treated PRP but none with the patient's own PRP.
Malondialdehyde formation, serum thromboxane B2 (TXB2) production and the generation of thromboxane B2 from PRP after stimulation with 2,ug/ml collagen and 1 mmoVI arachidonic acid, and plasma 6-keto prostaglandin F,a levels are shown from the patient and a normal subject who had ingested 900 mg of aspirin 12 hours previously in Table 1 .
The patient's total platelet ATP and ADP contents and ATP/ADP ratio were within our normal range as previously reported.'4 The percentage release of platelet ATP and ADP after stimulation with A23187, collagen and PAF-acether are also shown for the patient and a normal control ( Table   2 ).
The total ATP and ADP contents and ATP/ADP ratio from washed platelets of the patient and a normal subject and the percentage release of platelet ATP and ADP after stimulation with A23187 are shown in Table 3 .
By light and electron microscopy the patient's platelets showed normal morphology and granule Defective platelet aggregation to the calcium ionophore A23187 
